Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee debates 340B transparency and pharmacy contracting; members seek more data before acting
Summary
Lawmakers and stakeholders debated a bill aimed at state action on the federal 340B drug-pricing program, focusing on transparency, in-state contract pharmacies and reporting; no final vote was taken and parties were asked to refine amendments.
Lawmakers, hospital representatives, pharmacists and industry advocates debated proposed state measures tied to the federal 340B Drug Pricing Program during the Industry, Business and Labor Committee hearing.
Testimony focused on two themes: whether hospitals and covered entities must report how they use savings from 340B-discounted drugs, and whether covered entities should be limited to contracting with pharmacies that have a physical presence in North Dakota. Proponents pressed for disclosure; hospitals and some pharmacies urged caution.
Don Larson of PhRMA described two proposed amendments designed to increase transparency: (1) restrict covered-entity contracts to pharmacies based in North Dakota, and (2)…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
